An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9386-9395

  Arita, Minetaro ^a   Nagata, Noriyo ^a   Iwata, Naoko ^a   Ami, Yasushi ^a   Suzaki, Yuriko ^a   Mizuta, Katsumi ^b   Iwasaki, Takuya ^c   Sata, Tetsutaro ^a   Wakita, Takaji ^a   Shimizu, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b YAMAGATA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENTEROVIRUS 71; FEMALE; GENOTYPE; HAND FOOT AND MOUTH DISEASE; HUMAN; HUMAN CELL; IMMUNIZATION; INOCULATION; LETHALITY; MONKEY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SURVIVAL; SYMPTOMATOLOGY; TISSUE SPECIFICITY; TREMOR; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CENTRAL NERVOUS SYSTEM; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; MACACA FASCICULARIS; NEUTRALIZATION TESTS; ORGAN SPECIFICITY; SURVIVAL ANALYSIS; TREMOR; VACCINES, ATTENUATED; VERO CELLS; VIRAL VACCINES;

HUMAN ENTEROVIRUS 71; MACACA FASCICULARIS;

EID: 34548162065     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02856-06     Document Type: Article

References (58)

1. Abubakar, S., H. Y. Chee, N. Shafee, K. B. Chua, and S. K. Lam. 1999. Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997. Scand. J. Infect. Dis. 31:331-335.
2. Arita, M., H. Horie, M. Arita, and A. Nomoto. 1999. Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J. Virol. 73:1066-1074.
3. Arita, M., N. Nagata, T. Sata, T. Miyamura, and H. Shimizu. 2006. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J. Gen. Virol. 87:3317-3327.
4. Arita, M., H. Shimizu, and T. Miyamura. 2004. Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity. J. Gen. Virol. 85:1933-1944.
5. Arita, M., H. Shimizu, N. Nagata, Y. Ami, Y. Suzaki, T. Sata, T. Iwasaki, and T. Miyamura. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 86:1391-1401.
6. Bodian, D. 1954. Viremia in experimental poliomyelitis. I. General aspects of infection after intravascular inoculation with strains of high and of low invasiveness. Am. J. Hyg. 60:339-357.
7. Brown, B. A., M. S. Oberste, J. P. Alexander, Jr., M. L. Kennett, and M. A. Pallansch. 1999. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73:9969-9975.
8. Brown, B. A., and M. A. Pallansch. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39:195-205.
9. Burns, C. C., J. Shaw, R. Campagnoli, J. Jorba, A. Vincent, J. Quay, and O. Kew. 2006. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J. Virol. 80:3259-3272.
10. Chang, L. Y., T. Y. Lin, K. H. Hsu, Y. C. Huang, K. L. Lin, C. Hsueh, S. R. Shih, H. C. Ning, M. S. Hwang, H. S. Wang, and C. Y. Lee. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682-1686.
11. Chumakov, M., M. Voroshilova, L. Shindarov, I. Lavrova, L. Gracheva, G. Koroleva, S. Vasilenko, I. Brodvarova, M. Nikolova, S. Gyurova, M. Gacheva, G. Mitov, N. Ninov, E. Tsylka, I. Robinson, M. Frolova, V. Bashkirtsev, L. Martiyanova, and V. Rodin. 1979. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60:329-340.
12. De Jesus, N., D. Franco, A. Paul, E. Wimmer, and J. Cello. 2005. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J. Virol. 79:14235-14243.
13. Dufresne, A. T., and M. Gromeier. 2004. A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc. Natl. Acad. Sci. USA 101:13636-13641.
14. Fujimoto, T., M. Chikahira, S. Yoshida, H. Ebira, A. Hasegawa, A. Totsuka, and O. Nishio. 2002. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol. Immunol. 46:621-627.
15. Gromeier, M., B. Bossert, M. Arita, A. Nomoto, and E. Wimmer. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958-964.
16. Hagiwara, A., I. Tagaya, and T. Yoneyama. 1978. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9:60-63.
17. Hashimoto, I., and A. Hagiwara. 1983. Comparative studies on the neurovirulence of temperature-sensitive and temperature-resistant viruses of enterovirus 71 in monkeys. Acta Neuropathol. (Berlin) 60:266-270.
18. Hashimoto, I., and A. Hagiwara. 1982. Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection. Neuropathol. Appl. Neurobiol. 8:149-156.
19. Hattori, M., M. Oseto, Y. Yamashita, M. Mori, H. Inouye, Y. Ishimaru, and S. Nakano. 1994. An epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Ehime in 1993. Annu. Rep. Ehime Prefectural Inst. Public Health Environ. Sci. 55:11-14.
20. Ho, M., E. R. Chen, K. H. Hsu, S. J. Twu, K. T. Chen, S. F. Tsai, J. R. Wang, and S. R. Shih. 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341:929-935.
21. Huang, C. C., C. C. Liu, Y. C. Chang, C. Y. Chen, S. T. Wang, and T. F. Yeh. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341:936-942.
22. Iizuka, N., M. Kohara, K. Hagino-Yamagishi, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J. Virol. 63:5354-5363.
23. Karber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Path. Pharm. 162:480.
24. Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:1302-1309.
25. Komatsu, H., Y. Shimizu, Y. Takeuchi, H. Ishiko, and H. Takada. 1999. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr. Neurol. 20:17-23.
26. Li, L., Y. He, H. Yang, J. Zhu, X. Xu, J. Dong, Y. Zhu, and Q. Jin. 2005. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J. Clin. Microbiol. 43:3835-3839.
27. Lin, K. H., K. P. Hwang, G. M. Ke, C. F. Wang, L. Y. Ke, Y. T. Hsu, Y. C. Tung, P. Y. Chu, B. H. Chen, H. L. Chen, C. L. Kao, J. R. Wang, H. L. Eng, S. Y. Wang, L. C. Hsu, and H. Y. Chen. 2005. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J. Med. Virol. 78:254-262.
28. Lin, T. Y., S. J. Twu, M. S. Ho, L. Y. Chang, and C. Y. Lee. 2003. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg. Infect. Dis. 9:291-293.
29. Lu, C. Y., C. Y. Lee, C. L. Kao, W. Y. Shao, P. I. Lee, S. J. Twu, C. C. Yeh, S. C. Lin, W. Y. Shih, S. I. Wu, and L. M. Huang. 2002. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol. 67:217-223.
30. Lu, H. H., L. Alexander, and E. Wimmer. 1995. Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120. J. Virol. 69:4797-4806.
31. Lum, L. C., K. T. Wong, S. K. Lam, K. B. Chua, A. Y. Goh, W. L. Lim, B. B. Ong, G. Paul, S. AbuBakar, and M. Lambert. 1998. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133:795-798.
32. Macadam, A. J., G. Ferguson, D. M. Stone, J. Meredith, S. Knowlson, G. Auda, J. W. Almond, and P. D. Minor. 2006. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J. Virol. 80:8653-8663.
33. McMinn, P., K. Lindsay, D. Perera, H. M. Chan, K. P. Chan, and M. J. Cardosa. 2001. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and western Australia. J. Virol. 75:7732-7738.
34. McMinn, P. C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107.
35. Minor, P. 1997. Poliovirus, p. 555-574. In N. Nathanson et al. (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, PA.
36. Minor, P. D. 1992. The molecular biology of polio vaccines. J. Gen. Virol. 73:3065-3077.
37. Mizuta, K., C. Abiko, T. Murata, Y. Matsuzaki, T. Itagaki, K. Sanjoh, M. Sakamoto, S. Hongo, S. Murayama, and K. Hayasaka. 2005. Frequent Importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43:6171-6175.
38. Mueller, S., D. Papamichail, J. R. Coleman, S. Skiena, and E. Wimmer. 2006. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity. J. Virol. 80:9687-9696.
39. Nagata, N., T. Iwasaki, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, H. Hasegawa, T. Sata, T. Miyamura, and H. Shimizu. 2004. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 85:2981-2989.
40. Nagata, N., H. Shimizu, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, T. Miyamura, T. Sata, and T. Iwasaki. 2002. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 67:207-216.
41. Nathanson, N. 2005. Virus perpetuation in populations: biological variables that determine persistence or eradication. Arch. Virol. Suppl. 19:3-15.
42. Nathanson, N., and J. R. Martin. 1979. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am. J. Epidemiol. 110:672-692.
43. Omata, T., M. Kohara, S. Kuge, T. Komatsu, S. Abe, B. L. Semler, A. Kameda, H. Itoh, M. Arita, E. Wimmer, and A. Nomoto. 1986. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58:348-358.
44. Pulli, T., P. Koskimies, and T. Hyypia. 1995. Molecular comparison of coxsackie A virus serotypes. Virology 212:30-38.
45. Sabin, A. B. 1965. Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA 194:872-876.
46. Sabin, A. B. 1956. Pathogenesis of poliomyelitis: reappraisal in the light of new data. Science 123:1151-1157.
47. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed., p, 13.19-13.25. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
48. Schmidt, N. J., E. H. Lennette, and H. H. Ho. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129:304-309.
49. Shimizu, H., A. Utama, N. Onnimala, C. Li, Z. Li-Bi, M. Yu-Jie, Y. Pongsuwanna, and T. Miyamura. 2004. Molecular epidemiology of enterovirus 71 infection in the western Pacific region. Pediatr. Int. 46:231-235.
50. Shimizu, H., A. Utama, K. Yoshii, H. Yoshida, T. Yoneyama, M. Sinniah, M. A. Yusof, Y. Okuno, N. Okabe, S. R. Shih, H. Y. Chen, G. R. Wang, C. L. Kao, K. S. Chang, T. Miyamura, and A. Hagiwara. 1999. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn. J. Infect. Dis. 52:12-15.
51. Shindarov, L. M., M. P. Chumakov, M. K. Voroshilova, S. Bojinov, S. M. Vasilenko, I. Iordanov, I. D. Kirov, E. Kamenov, E. V. Leshchinskaya, G. Mitov, I. A. Robinson, S. Sivchev, and S. Staikov. 1979. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23:284-295.
52. Tano, Y., H. Shimizu, M. Shiomi, T. Nakano, and T. Miyamura. 2002. Rapid serological diagnosis of enterovirus 71 infection by IgM ELISA. Jpn. J. Infect. Dis. 55:133-135.
53. Tardy-Panit, M., B. Blondel, A. Martin, F. Tekaia, F. Horaud, and F. Delpeyroux. 1993. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J. Virol. 67:4630-4638.
54. Wallis, C., and J. L. Melnick. 1967. Virus aggregation as the cause of the non-neutralizable persistent fraction. J. Virol. 1:478-488.
55. Wang, J. R., Y. C. Tuan, H. P. Tsai, J. J. Yan, C. C. Liu, and I. J. Su. 2002. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 40:10-15.
56. Wang, S. M., H. Y. Lei, K. J. Huang, J. M. Wu, J. R. Wang, C. K. Yu, I. J. Su, and C. C. Liu. 2003. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188:564-570.
57. Wang, S. M., C. C. Liu, H. W. Tseng, J. R. Wang, C. C. Huang, Y. J. Chen, Y. J. Yang, S. J. Lin, and T. F. Yeh. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29:184-190.
58. Wenner, H. A., P. Harmon, A. M. Behbehani, H. Rouhandeh, and P. S. Kamitsuka. 1967. The antigenic heterogeneity of type 30 echoviruses. Am. J. Epidemiol. 85:240-249.